P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP
Authors:
Open Access
- 8 August 2023
- journal article
- abstracts
- Published by Wiley in HemaSphere
- Vol. 7 (S3) , e27391ea